26 September 2024 - BEAM AllianceNew York, From inside the UN buildings – Remko van LeeuwenJust a few hours ago the General Assembly of the UN has adopted a new declaration on fighting AMR. Regardless…read more >>
17 September 2024 - BEAM AllianceBEAM’s Reflection paper on General Pharmaceutical Legislation Revision: Taking Stock of the EU Parliament Position and Moving ForwardThe BEAM Alliance would like to reiterate its call for optimal PULL incentives designed to fit innovators’ needs based on…read more >>
24 October 2023 - BEAM AllianceBEAM Alliance shares its views on the ongoing revision of the General Pharmaceutical LegislationWe call on policymakers to stop postponing decisions and either propose a clear incentive package now or reintroduce the TEE…read more >>
05 September 2023 - BEAM AllianceBEAM Alliance is Launching a new Task Force to address Issues from the AMR Diagnostics SegmentThe new Task Force is gathering innovative SMEs operating in the AMR field and external experts.read more >>
16 June 2023 - BEAM AllianceBEAM’s reflection paper on the possible roles of DG HERAThe report represents an important step towards the implementation of a tangible solution to fix the AMR market. Although the…read more >>
23 May 2023 - BEAM AllianceBEAM’s statement on the EU Council Recommendation on AMRThe proposal examines AMR in a rather exhaustive way. It includes provisions on the need to strengthen national action plans,…read more >>
08 January 2025 - BasileaBasilea provides portfolio update and outlookThroughout 2025, we aim to continue both progressing our current R&D assets and expanding our portfolio through targeted in-licensing and…read more >>
23 December 2024 - BasileaBasilea is awarded additional CARB-X funding to develop new drug candidate from a novel class of antibioticsLptA inhibitors have the potential to address an unmet medical need in the hospital-based treatment of severe infections, caused by…read more >>
16 December 2024 - BasileaBasilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera® (ceftobiprole) in the United StatesCeftobiprole, the active moiety of the prodrug ceftobiprole medocaril, is an advanced generation cephalosporin antibiotic for intravenous administration, with rapid…read more >>
25 November 2024 - Centauri Therapeutics LtdCentauri Therapeutics awarded £1M grant under new PACE programme to advance immunotherapy platform in anti-infectives“We are excited to have support from PACE as we progress the development of our molecules in anti-infectives, and de-risk…read more >>
21 November 2024 - Debiopharm InternationalCARB-X Awards Additional Funding to Debiopharm for Continued Development of Early-Stage Antibiotic Targeting Drug-Resistant N. Gonorrhoeae InfectionsNow more than ever, new antibiotics are needed to avoid serious public health consequences caused by this infection.read more >>
13 November 2024 - AktheliaAkthelia Pharmaceuticals featured in Icelandic newspaper ViðskiptablaðiðThe article highlights the opportunity to advance our highly promising oral NCE therapeutic asset Gastrimod™️ (AKT-011) that we are exploring…read more >>
27 June 2024REVIVE Webinar: Progressing an antibacterial drug discovery project – an SME perspectiveAlisa Serio from Paratek Pharma and Victoria Savage from INFEX Therapeutics will focus on the particular challenges, progression criteria and…read more >>
23 April 2024REVIVE Webinar: Efflux inhibitors: A strategy to tackle multidrug resistanceThe next REVIVE webinar will feature an overview of bacterial efflux and how molecules designed to inhibit this can be…read more >>
18 April 2024BEAM webinar – Swiss RTA: Why do we need a pull incentive to push antibiotics onto the market?BEAM is excited to host a series of webinars setup by its Associated Organizations.read more >>
09 April 2024REVIVE Webinar: Progressing a discovery project – Criteria and challengeswith Ken Bradley, Global Head, Infectious Disease Discovery, Roche and Diarmaid Hughes, Professor of Medical Molecular Bacteriology, Uppsala University (Sweden)read more >>
21 March 2024BEAM webinar – BioAster: Novel technologies with an AI-facilitated approachBEAM is excited to host a series of webinars setup by its Associated Organizations.read more >>
18 March 2024BIO-Europe Spring ® 2024 – 18th Annual International Partnering ConferenceReconnecting and facilitating global partnershipsread more >>
06 March 20248th AMR ConferenceThe AMR conference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and…read more >>
27 February 2024GARDP Webinar – What does the future look like if pull incentives to support antibiotic R&D are insufficient?This webinar will discuss potential solutions, including support for non-profit R&D organizations, to get new treatments to patients in the…read more >>
06 February 2024Antimicrobial Chemotherapy Conference (ACC) 2024 – Free Online ConferenceThis virtual conference is jointly organised by GARDP and BSAC.read more >>
